Capecitabine in Treating Women With Advanced or Metastatic Breast Cancer
Public ClinicalTrials.gov record NCT00026442. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Pilot Trial Of Two Different Doses Of Capecitabine (XELODA) In Patients With Advanced And/Or Metastatic Breast Cancer
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Randomized phase II trial to compare the effectiveness of two different doses of capecitabine in treating women who have advanced or metastatic breast cancer.
Study identification
- NCT ID
- NCT00026442
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- Not listed
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2001 (Type not available)
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Dec 18, 2013
Started 2001
United States locations
- U.S. sites
- 10
- U.S. states
- 7
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Antelope Valley Hospital | Lancaster | California | 93534 | — |
| Medical Oncology Care Associates | Orange | California | 92868 | — |
| California Cancer Medical Center | West Covina | California | 91790 | — |
| Oncology Clinic, P.C. | Colorado Springs | Colorado | 80907 | — |
| Hematology Oncology Associates of theTreasure Coast - Port St. Lucie | Port Saint Lucie | Florida | 34952 | — |
| North Florida Cancer Center | Saint Augustine | Florida | 32086 | — |
| Maryland Hematology/Oncology Associates | Baltimore | Maryland | 21236 | — |
| Charleston Hematology-Oncology, P.A. | Charleston | South Carolina | 29403 | — |
| Family Cancer Center | Collierville | Tennessee | 38017 | — |
| Logan Regional Hospital | Logan | Utah | 84341 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00026442, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 18, 2013 · Synced Oct 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00026442 live on ClinicalTrials.gov.